Literature DB >> 8061586

Toward a physiological approach to breast cancer prevention.

J Russo1, I H Russo.   

Abstract

Breast cancer is one of the most frequent malignancies in women, and its incidence is increasing. No reduction in the mortality rate has resulted from advances in early diagnosis and new therapeutic modalities; therefore, new approaches to the understanding of this disease are required. The observation that, in an experimental animal model, full-term pregnancy prior to exposure to a carcinogenic agent protects the mammary gland from malignant transformation led us to study the mechanisms underlying this phenomenon. The protective effect observed after pregnancy did not depend upon gestational or lactational hyperplasia of the mammary gland, but upon structural changes induced in the mammary parenchyma by those processes. Those changes are permanent, since the protective effect is maintained after pregnancy and consists in the complete differentiation of terminal end buds to lobules. The protective effect exerted by pregnancy can be mimicked by treating young virgin rats with a single placental hormone, chorionic gonadotropin. Since the possibility of preventing breast cancer by treating young nulliparous females with hormones that mimic a fullterm pregnancy that results in complete differentiation of the gland is of practical interest to the human female population, we undertook the study of the human breast. The breast of postpubertal nulliparous women is composed of lobular structures reflecting different stages of development. Lobules type 1 (lob 1) are the most undifferentiated ones. Lobules type 2 evolve from the previous ones and have a more complex morphology, being composed of a higher number of ductular structures per lobule. They progress to lobules type 3 and 4, which are present in the pregnant and lactational periods of the mammary gland. In nulliparous women the structure most frequently found at all ages is the lob 1, whereas in parous women, lob 3 is the most frequent one. Lob 1 are considered to be the site of origin of ductal carcinoma in situ, which progresses to invasive carcinoma. Lob 2 originate lobular carcinoma and lob 3 originate adenomas, fibroadenomas, sclerosing adenosis, and apocrine cysts. These observations led us to test if the degree of lobular development influences the transformation of human breast epithelial cells exposed in vitro to chemical carcinogens. We found that primary cultures derived from breast tissues composed of lobules type 1 and 2 express phenotypes of cell transformation which were not observed in cells derived from lobules type 3.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061586

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  51 in total

1.  Mortality associated with oral contraceptive use. Confounding might have accounted for results.

Authors:  A Szarewski; H C Kitchener
Journal:  BMJ       Date:  1999-08-07

Review 2.  Apoptosis in the estrous and menstrual cycles.

Authors:  A C Andres; R Strange
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

3.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

Authors:  Hongjuan Zhao; Anita Langerød; Youngran Ji; Kent W Nowels; Jahn M Nesland; Rob Tibshirani; Ida K Bukholm; Rolf Kåresen; David Botstein; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
Journal:  Mol Biol Cell       Date:  2004-03-19       Impact factor: 4.138

4.  Direct action of estrogen on sequence of progression of human preneoplastic breast disease.

Authors:  M P Shekhar; P Nangia-Makker; S R Wolman; L Tait; G H Heppner; D W Visscher
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

5.  Smoking before the first pregnancy and the risk of breast cancer: a meta-analysis.

Authors:  Lisa A DeRoo; Peter Cummings; Beth A Mueller
Journal:  Am J Epidemiol       Date:  2011-06-30       Impact factor: 4.897

6.  Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies.

Authors:  Heather J Baer; Laura C Collins; James L Connolly; Graham A Colditz; Stuart J Schnitt; Rulla M Tamimi
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

7.  Decreasing hormonal promotion is key to breast cancer prevention.

Authors:  Lakshmanaswamy Rajkumar; Amy Canada; David Esparza; Katherine Collins; Enrique Moreno; Huyen Duong
Journal:  Endocrine       Date:  2009-02-12       Impact factor: 3.633

8.  Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.

Authors:  Huiyan Ma; Katherine D Henderson; Jane Sullivan-Halley; Lei Duan; Sarah F Marshall; Giske Ursin; Pamela L Horn-Ross; Joan Largent; Dennis M Deapen; James V Lacey; Leslie Bernstein
Journal:  Breast Cancer Res       Date:  2010-06-18       Impact factor: 6.466

9.  Do placental genes affect maternal breast cancer? Association between offspring's CGB5 and CSH1 gene variants and maternal breast cancer risk.

Authors:  Yu Chen; Muhammad G Kibriya; Farzana Jasmine; Regina M Santella; Ruby T Senie; Habibul Ahsan
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

10.  Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival.

Authors:  Vaibhav P Pai; Aaron M Marshall; Laura L Hernandez; Arthur R Buckley; Nelson D Horseman
Journal:  Breast Cancer Res       Date:  2009-11-10       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.